Targeting Fibrosis in Kidney, Bone Marrow, and Urological Diseases
Download the Meeting Minutes (PDF, 145.54 KB) .
Discuss Means of Detecting and Measuring Pathologic Fibrosis in Humans
Questions to be answered
- Can we differentiate between pathologic fibrosis and that of normal aging?
- Does fibrosis correlate with organ dysfunction?
- Does imaging of fibrosis correlate with organ dysfunction, recovery, and regression?
- What novel biomarkers or technologies should be pursued to detect and measure pathologic fibrosis?
Tamara Bavendam, Terry Bishop, Ed Doo, Deborah Hoshizaki, Chris Ketchum,
Ziya Kirkali, Maren Laughlin, Tracy Rankin, and Krystyna Rys-Sikora
Hyatt Regency Bethesda Hotel
One Bethesda Metro Center
7400 Wisconsin Avenue
Bethesda, MD 20814
T: +1-301-657-1234 or 800-233-1234
Michael F. Flessner, M.D., Ph.D.
John Hare, M.S., CMP, CGMP
The Scientific Consulting Group, Inc.